EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS162-00861 
Organism
Homo sapiens 
Tissue/cell
Plasma_cell_myeloma 
Coordinate
chr1:192573690-192574930 
TF binding sites/motifs
Number: 6             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ZNF263MA0528.1chr1:192574867-192574888GATGGAAGGAGGAAGGGAGGG+6.06
ZNF263MA0528.1chr1:192574879-192574900AAGGGAGGGAGGGGGAGAAAG+6.24
ZNF263MA0528.1chr1:192574889-192574910GGGGGAGAAAGAGAATGAGAG+6.36
ZNF263MA0528.1chr1:192574883-192574904GAGGGAGGGGGAGAAAGAGAA+7.46
ZNF263MA0528.1chr1:192574874-192574895GGAGGAAGGGAGGGAGGGGGA+8.37
ZNF263MA0528.1chr1:192574871-192574892GAAGGAGGAAGGGAGGGAGGG+9.25
Number of super-enhancer constituents: 6             
IDCoordinateTissue/cell
SE_43694chr1:192571742-192577024MM1S
SE_58423chr1:192573180-192611301Ly1
SE_59607chr1:192571834-192620763Ly4
SE_60433chr1:192573416-192610588DHL6
SE_61104chr1:192573010-192610405HBL1
SE_61454chr1:192540780-192610346Toledo
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr1192574180192574494
chr1192574140192574567
Number: 1             
IDChromosomeStartEnd
GH01I192605chr1192574180192574494
Enhancer Sequence
AATCATGCTG ACAATAGATT CTTGAGATAA ATTTCATTTC AATAATGTAT AGATTGTATG 60
CAAAGAAATG GACCTGGATA ATGCTTTTTG ATGGTTTCTA ACTTTATTCC AAGTCTATAG 120
TCTTTGTGAG TAGAGGACTA AATTGAATCT GGGCTCCACC AAGAAAAAAA TAGGTGACCT 180
AGGACAAGTC ATTTAACTTC TTTAGTTTAT TTACTTTATT TATTTAGTTT ATTTATTTAG 240
TTAGTTAGTT TATCTGTATT TACTTATACA GATAACTATA ATAAATGCCC TGTCTTCCTC 300
AAGATCATAT TATAAAAATT GTGTTAAAAA ACTTATATCA AAATGCTTTA CAAGTAATGT 360
TTTACATAAA ATTTAATTAT TATGAATAAA TAGAACCTTT AAAAACTAAA TCTTTCAAGA 420
TTATATTCAT TCAAATGGAA ATAGCTAAAT TTGTGCATGA ATATCAGATG ACTTCTTCCT 480
GCCTTGGTTA CTAATGAATG GCCAAGCTTG TTTCTATAAA TAAATGGGCA CTGGCATATT 540
TTTTAAAAAA TACATGTGGC TCAAGATTAG ACTTCTTCCG CTTTGTGGTA TCACATGTCT 600
GACCACAGCA ACTATTTTAA ATCATGGTCT ATGCTTTTAA TGACATCTAA CTCCACACAA 660
AGAGTCATCA TTTTTATCTA GACGTGTGTG ACGTGCTTGA TTGCAATGTG TTTTTTTTTT 720
GTGTGTGTGT GTTGTTGTTT TTCTCTTTAT CATTTTAACA TGCATTTCTA TAATACTTTG 780
GTAATCTTGA AAACACTCAG GTCACCTTAC AACATCAAGA CAGGCATAGA CCACTGTTTC 840
CTTAAGTCTA TAAAGTTTTG TTATAAAAAT TGGGTAGCCA GCTGTTCTTG GCCTAACATT 900
AATCTAATAA AAGTGTTTCC AAAGAAAGTT TATGGAATGA AAATTCATTG CTATTATTTT 960
CAACTTTAAT TGAATTTTTA AATAAAAACA CTAAAAACTA AACAATAGTA TTGAATACTA 1020
CTATTGGAAT TCATAGCTGG GCATGGCAGT GCATGCCTAT AATCCCAGCT ACTCAGGATG 1080
CTGAGGCAGA AGGACTACTT GAGGCCAGAA GTTTGAGACT AGCCTGAGCA ATATAGAAAA 1140
TCCTGTCTTA CATGAAATAC AGAAAGAAAG AGAGACAGAT GGAAGGAGGA AGGGAGGGAG 1200
GGGGAGAAAG AGAATGAGAG AAAGAGAGAG GAGAGAGGGA 1240